1985PubMedRequires access

[Preliminary results of Re-PUVA therapy in cutaneous T-cell lymphomas].

B Thiele, H Rasokat, G. Mahrle

Open publisher page 2 citations

Abstract

Eight patients with T-cell-lymphoma of the skin (6 mycosis fungoides, 2 parapsoriasis variegata) were treated with Tigason in combination with PUVA-therapy. The daily dose of Tigason was 50-100 mg. There was complete regression of skin lesions in three patients, partial regression in three patients, and an improvement in two patients.

About this research paper

What this paper is about

Eight patients with T-cell-lymphoma of the skin (6 mycosis fungoides, 2 parapsoriasis variegata) were treated with Tigason in combination with PUVA-therapy. The daily dose of Tigason was 50-100 mg. There was complete regression of skin lesions in three patients, partial regression in three patients, and an improvement in two patients.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Eight patients with T-cell-lymphoma of the skin (6 mycosis fungoides, 2 parapsoriasis variegata) were treated with Tigason in combination with PUVA-therapy. The daily dose of Tigason was 50-100 mg. There was complete regression of skin lesions in three patients, partial regression in three patients, and an improvement in two patients.

Key concepts: Mycosis fungoides, PUVA therapy, Dermatology, Medicine, Cutaneous T-cell lymphoma, Lymphoma, Peripheral T-cell lymphoma, Psoriasis

Related papers

Back to paper searchBrowse research topicsOriginal source
[Preliminary results of Re-PUVA therapy in cutaneous T-cell lymphomas]. — Research Paper | ScholarLens